CClinicalTrials.gg
CompletedNCT02109263ACTISUCROSEUpdated Dec 3, 2025

Prevention of the Procedural Pain in the Newborn

An interventional study of saccharose versus breast-feeding in Prevention of the Procedural Pain in the Newborn, sponsored by University Hospital, Brest. Completed at 1 site in France. Open to participants aged 37 Weeks to 42 Weeks. Per ClinicalTrials.gov, last updated 2025-12-03.

Sponsored by University Hospital, Brest · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
37 Weeks to 42 Weeks
Sex
All
01

Study summary

The aim of this study is to compare the impact of two non-medicinal strategies: the breast-feeding and saccharose to measure effects in cerebral cortex during pain using near infrared spectroscopy (NIRS)

Read the detailed description

Many studies of non-medicinal treatments(saccharose and breast-feeding)show a decrease of expression of pain in newborn. However Slater and al questioned these practices due to the absence of modification of the cerebral answer measured by evoked potential.

02

Conditions studied

  • Prevention of the Procedural Pain in the Newborn

Browse trials for

Keywords

  • Breast-feeding
  • Saccharose
  • Breast-feeding newborn
  • cortical pain responses
  • near infrared spectroscopy (NIRS)
  • Salivary rate cortisol
  • heel lance
03

In context

Breast Feeding

262 studies on the registry are indexed under Breast Feeding; 112 are open to participants now.

This study's enrollment of 114 is above the median of 95 across 210 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
37 Weeks to 42 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Gestationnel age included between 37 and 42 weeks
  • Born in the CHRU of Brest
  • Breast-Fed
  • Score of Apgar upper to 7
  • No pathology malformative
  • Absence of known chromosomal abnormality
  • Consent of parents

Exclusion criteria

Exclusion Criteria:

  • Maternal drug use
  • Morphinic treatment
  • Barbiturate treatment
  • Benzodiazépine treatment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
114 participants (actual)

Study arms

  • Experimental
    saccharose

    20% saccharose

    Procedure: saccharose versus breast-feeding

  • Placebo comparator
    breast-feeding

    breast-feeding

    Procedure: saccharose versus breast-feeding

Interventions

  • Proceduresaccharose versus breast-feeding

    saccharose versus breast-feeding

06

What researchers measure

Primary outcomes

  1. Increase of the total concentration of haemoglobin

    Increase of the total concentration of haemoglobin (delta HbT) measured by the spectrometer during the intravenous injection.

    Time frame: Measure two minutes before painful gesture, at the moment of painful gesture and 2 minutes after painful gesture. The newborn will be followed for the duration of hospital stay, an expected average of 30 to 60 minutes

Secondary outcomes

  1. Dosage of rate salivary cortisol

    Salivary cortisol sampling

    Time frame: before and after painful gesture

07

Study locations

1 site
  • Centre hospitalier universitaire
    Brest, 29200, France
08

References and documents

Publications

  • Rioualen S, Durier V, Herve D, Misery L, Sizun J, Roue JM. Cortical Pain Response of Newborn Infants to Venepuncture: A Randomized Controlled Trial Comparing Analgesic Effects of Sucrose Versus Breastfeeding. Clin J Pain. 2018 Jul;34(7):650-656. doi: 10.1097/AJP.0000000000000581. PubMed 29298184 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02109263
Lead sponsor
University Hospital, Brest
Responsible party
Sponsor
First posted
Apr 9, 2014
Start date
Jun 2013
Primary completion
Dec 2013
Completion
Dec 2013
Last update
Dec 3, 2025

Study contacts

Jean-Michel ROUE
principal investigator · Pole de la femme, de la Mère et de l'Enfant, CHRU de Brest

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion